VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin’s disease

✍ Scribed by Ribrag, V; Nasr, F; Bouhris, J H; Bosq, J; Brault, P; Girinsky, T; Cosset, J M; Munck, J N; Corti, C; Decaudin, D

• Book ID: 110010520
• Publisher: Nature Publishing Group
• Year: 1998
• Tongue: English
• Weight: 58 KB
• Volume: 21
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/sj.bmt.1701202